Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B Cell Lymphoma

Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

165 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B Cell Lymphoma trial results

Recruiting

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

NCT05365659

Conditions
B-Cell Non-Hodgkin Lymphoma, B-cell Lymphoma, Diffuse Large B Cell Lymphoma, +15 more
Locations
  • University of Maryland Baltimore Baltimore, Maryland, United States
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Royal Hobart Hospital Hobart, Tasmania, Australia
View all 13 locations
View Trial Details
Recruiting

Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma

NCT05326243

Conditions
Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, Follicular Lymphoma Grade 3B, +13 more
Locations
  • National Taiwan University Hospital Taipei, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
  • Taipei Medical University - Taipei Medical University Hospital Taipei, Taiwan
View Trial Details
Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

NCT05377307

Conditions
Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, +16 more
Locations
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Taipei Veterans General Hospital Taipei, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
View Trial Details

Related conditions